Compound ID | 926
Class: Aminoacyl-tRNA synthetase inhibitor (phenylanalyl-tRNA synthetase [PheRS] inhibitor)
| Spectrum of activity: | Gram-negative |
| Institute where first reported: | Cubist Pharmaceuticals (Merck & Co, USA) |
| Year first mentioned: | 2001 |
| Highest developmental phase: | Preclinical |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| Citation: | https://www.drugfuture.com/synth/syndata.aspx?ID=288178 |